Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

173 Views

Poster Session: Infections in Immunocompromised Individuals

2108 - Evaluation of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection in Patients Living With Cancer at a Large Comprehensive Cancer Center

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Jaime A. Peña, PharmD

Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Co-Author(s)

NV

Nancy N. Vuong, PharmD

Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Pablo C. Okhuysen, MD

Professor
The University of Texas MD Anderson Cancer Center
Houston, TX, United States
MM

Mark F. Munsell, MS

Principal Biostatistician
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States